We previously reported that TRPV4 KO mice are protected from pro‐fibrotic effects of bleomycin in lung and skin,29, 30 and bleomycin has been shown to cause EMT in skin and pulmonary fibrosis model.17, 62 To determine whether TRPV4 deficiency could also suppress EMT in an experimental model of skin fibrosis, we employed the bleomycin‐induced skin fibrosis model, and analysed expression of EMT markers between bleomycin or phosphate‐buffered saline (PBS) treated TRPV4 KO and WT mice. The gene discussed is TRPV4; the disease is pulmonary fibrosis.